PERKINELMER INC. news, videos and press releases
For more news please use our advanced search feature.
PERKINELMER INC. - More news...
PERKINELMER INC. - More news...
- Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System
- PerkinElmer Board Declares Quarterly Dividend
- PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
- PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
- PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
- PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
- PerkinElmer to Present at Upcoming Investor Conferences
- PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
- PerkinElmer Board Declares Quarterly Dividend
- PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
- PerkinElmer to Present at J.P. Morgan Healthcare Conference
- PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
- PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
- PerkinElmer to Present at 2022 Stifel Healthcare Conference
- PerkinElmer Announces Financial Results for the Third Quarter of 2022
- PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
- PerkinElmer Board Declares Quarterly Dividend
- PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
- PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
- PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
- PerkinElmer to Present at Upcoming Investor Conferences
- PerkinElmer Announces Financial Results for the Second Quarter of 2022
- PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
- PerkinElmer Board Declares Quarterly Dividend
- PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
- PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
- PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
- PerkinElmer Launches BioQule NGS System to Automate Library Preparation
- PerkinElmer Announces Financial Results for the First Quarter of 2022
- PerkinElmer Board Declares Quarterly Dividend
